The Worldwide Breast Lesion Localization Methods Industry is Expected to Grow at a CAGR of 7.5% Between 2020 & 2025

News provided by

Dec 21, 2020, 16:00 ET

DUBLIN, Dec. 21, 2020 /PRNewswire/ -- The "Breast Lesion Localization Methods Market By Type (Wire, Radioisotope [Radio Occult], Magnetic), Usage (Tumor Identification, Sentinel Lymph Node [Lumpectomy]), End User Preference Survey (Selection Criteria, Replacement Trend) - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.

The market for breast lesion localization methods is expected to grow from 3,974.4 thousands of procedures in 2020 to 5750.9 thousands of procedures by 2025, at a CAGR of 7.5% during the forecast period.

The breast lesion localization methods market is driven primarily by the increasing incidence of breast cancer, rising number of breast cancer surgeries, and growing awareness on the early detection of breast cancer. However, uncertainty in regulatory approval procedures is expected to restrain the growth of this market during the forecast period.

The COVID-19 pandemic has largely impacted healthcare delivery globally since December 2019. Non-essential procedures related to breast cancer care and routine breast screening programs have been postponed in many countries as healthcare resources are diverted to handle the pandemic crisis. The selection of the type of breast lesion localization method in the current scenario and in the post lockdown period can be considered from three aspects: time taken for procedure, re-operation/re-excision rates and cost of the breast lesion localization device.

Revised guidelines for breast cancer care have been suggested by cancer organizations and oncologists in most regions, most of which focus on minimizing outpatient and inpatient admissions and staggering schedules to reduce patient influx daily. The time taken for the procedure becomes crucial in this scenario for the convenience of patients and healthcare providers and also to lower the chances of spread of viral infection. In this case, healthcare providers may not favor wire-guided localization (WGL) procedures as they require almost twice as much time as other procedures. Moreover, the chances of re-excision in case this procedure are also high.

The wire localization segment held the largest share of the breast lesion localization methods market in 2020.

Based on type, the breast lesion localization methods market is divided into five major segments - wire localization, isotope localization, magnetic localization, electromagnetic localization, and others. The wire localization segment accounted for the largest share of the breast lesion localization methods market in 2020. The large share of this segment is attributed to its accuracy in abnormal tissue localization, minimum removal of normal tissues, minimal scarring, and the availability of reimbursement for breast lesion localization devices.

Asia Pacific accounted for the largest share and is projected to grow at the highest CAGR during the forecast period.

The Asia Pacific accounted for the largest share and is projected to record the highest growth in the breast lesion localization methods market during the forecast period. The rapidly increasing patient population, increasing healthcare expenditure, improving healthcare infrastructure, high government spending on breast cancer research, and increasing awareness are the major factors supporting the growth of the Asia Pacific breast lesion localization methods market.

The report also contains a detailed analysis of end-user preference for the adoption of different breast lesion localization methods. The research findings cited in the report encapsulates the important selection criteria for breast lesion localization methods from an end-user point of view. It analyses importance given to the particular criteria while selecting a breast lesion localization methods. Important criteria for the selection of breast lesion localization methods include detection and success rate, re-excision rate, cost, mean localization time, effectiveness, safety, and ease of use.

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights
4.1 Breast Lesion Localization Methods Market Overview
4.2 Asia Pacific: Breast Lesion Localization Methods Market, 2019
4.3 Breast Lesion Localization Methods Market: Geographic Mix

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.3 Drivers
5.3.1 Growing Incidence Of Breast Cancer
5.3.2 Increasing Number Of Breast Cancer Surgeries
5.3.3 Increasing Awareness On The Early Detection Of Breast Cancer
5.4 Restraints
5.4.1 Uncertainty In Regulatory Approval Procedures
5.5 Opportunities
5.5.1 Emerging Economies Offer High Growth Potential
5.5.2 Increasing Adoption Of Technologically Advanced Localization Procedures
5.6 Challenges
5.6.1 Shortage Of Oncologists
5.7 Impact Of COVID-19 On The Breast Lesion Localization Market: Restructuring Of Breast Cancer Care
5.8 Adjacent Market Tables

6 Industry Insights
6.1 Industry Trends
6.1.1 Electromagnetic Waves For Localization Of Breast Lesions
6.1.2 Radiofrequency Identification In Breast Lesion Localization
6.1.3 Machine Learning Algorithms For Computer-Aided Breast Lesion Detection
6.1.4 Reimbursement Guidelines For Breast Lesion Localization Device Placement

7 Breast Lesion Localization Methods Market, By Type
7.1 Introduction
7.2 Wire Localization
7.3 Radioisotope Localization
7.3.1 Radioguided Occult Lesion Localization (Roll)
7.3.2 Radioactive Seed Localization (Rsl)
7.4 Magnetic Localization
7.5 Electromagnetic Localization
7.6 Other Localization Methods
7.7 COVID-19 Impact On The Breast Lesion Localization Methods Market, By Type

8 Breast Lesion Localization Market, By Usage
8.1 Introduction
8.2 Sentinel Lymph Node Identification
8.2.1 Lumpectomy
8.2.1.1 High Survival Rates Favor The Adoption Of Lumpectomy
8.2.2 Mastectomy
8.2.2.1 There Is A Low Risk Of Cancer Recurrence In Mastectomy
8.3 Tumor Identification
8.3.1 Increasing Focus On Early Breast Cancer Detection Driving The Growth Of The Tumor Identification Segment

9 Breast Lesion Localization Methods Market, By Region
9.1 Introduction
9.2 Asia Pacific
9.2.1 COVID-19 Impact On The Breast Lesion Localization Methods Market In The Asia Pacific
9.3 Europe
9.3.1 COVID-19 Impact On The Breast Lesion Localization Methods Market In Europe
9.3.2 Germany
9.3.3 France
9.3.4 UK
9.3.5 Rest Of Europe
9.4 North America
9.4.1 COVID-19 Impact On The Breast Lesion Localization Methods Market In North America
9.4.2 US
9.4.2.1 US To Dominate The North American Breast Lesion Localization Market
9.4.3 Canada
9.4.3.1 Increasing Incidence Of Breast Cancer And Government Initiatives For Breast Cancer Awareness To Drive Market Growth In Canada
9.5 Rest Of The World
9.5.1 COVID-19 Impact On The Breast Lesion Localization Methods Market In The Rest Of The World

10 Competitive Landscape
10.1 Introduction
10.2 Competitive Leadership Mapping (Overall Market)
10.3 Vendor Inclusion Criteria
10.4 Vendor Dive
10.4.1 Visionary Leaders
10.4.2 Innovators
10.4.3 Dynamic Differentiators
10.4.4 Emerging Companies
10.5 Geographical Assessment Of The Major Players In The Breast Lesion Localization Methods Market
10.6 Competitive Assessment Of R&D Expenditure
10.7 Market Share Analysis
10.7.1 Market Share Analysis: Global Breast Lesion Localization Methods Market
10.8 Competitive Scenario
10.9 Breast Lesion Localization Methods: Comparative Analysis
10.10 Breast Lesion Localization Methods: Comparative Analysis
10.11 Breast Lesion Localization Methods: Selection Criteria Evaluation
10.12 Qualitative Assessment Of Replacement Trends

11 Company Profiles
11.1 Hologic, Inc.
11.2 Becton, Dickinson And Company
11.3 Cianna Medical, Inc.
11.4 Leica Biosystems
11.5 Argon Medical Devices, Inc.
11.6 Laurane Medical
11.7 Endomagnetics Limited
11.8 Health Beacons, Inc.
11.9 Intra-Medical Imaging
11.1 Isoaid
11.11 Somatex Medical Technologies
11.12 Surgiceye Gmbh
11.13 Ranfac Corporation
11.14 Mermaid Medical Group
11.15 Izi Medical
11.16 Matek Medical Inc.
11.17 Tsunami Medical
11.18 BPB Medica
11.19 Sirius Medical Bv
11.20 Molli Surgical Inc.

12 Adjacent/Related Market - Breast Imaging Market
12.1 Introduction
12.2 Breast Imaging Market
12.2.1 Market Definition
12.2.2 Limitations
12.2.3 Market Overview
12.3 Breast Imaging Market, By Region
12.4 Breast Imaging Market, By Technology
12.4.1 Ionizing Breast Imaging Technologies Market
12.4.2 Mammography
12.4.3 Positron Emission Tomography-Computed Tomography (Pet-Ct)
12.4.3.1 Combined Scans From Pet And Ct Provide A More Accurate Diagnosis As Compared To The Individual Scans Performed
12.4.4 Molecular Breast Imaging
12.4.4.1 Mbi Technique Is Simple, Fast, And Highly Sensitive And Can Be Used For Patients Who Are Claustrophobic Or Allergic To Gadolinium
12.4.5 Positron Emission Mammography
12.4.5.1 Pem Involves Radiation Exposure Throughout The Body, Which Increases The Risk Of Cancer - A Major Disadvantage Associated With This Technique
12.5 Non-Ionizing Breast Imaging Technologies
12.5.1 Breast Ultrasound
12.5.1.1 Lower Cost, Increasing Awareness, And Easy Availability Of Ultrasound Devices For Breast Imaging Are Driving The Growth Of This Market
12.5.2 Breast Mri
12.5.2.1 Technological Advancements In Breast Mri And The Rising Demand For Technologies That Involve Minimal Use Of Radiation Are The Key Factors Driving The Growth Of This Market
12.5.3 Automated Whole-Breast Ultrasound
12.5.3.1 Awbu Helps Spot Tiny Cancers In The Mammogram Of Fatty Breasts
12.5.4 Breast Thermography
12.5.4.1 This Technique Is Not Effective When Used As A Standalone Test For Breast Cancer Screening
12.6 Other Breast Imaging Technologies
12.6.1 Optical Imaging
12.6.2 Cone-Beam Computed Tomography
12.6.3 Electric Impedance Tomography

13 Appendix
13.1 Discussion Guide
13.2 Knowledge Store: Subscription Portal
13.3 Available Customizations
13.4 Related Reports
13.5 Author Details

For more information about this report visit https://www.researchandmarkets.com/r/jdt7uo

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets